Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Targan

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Alimentary Pharmacology & Therapeutics|July 13, 2012
Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolismD Q Shih, M Nguyen, L Zheng, et al.
Inflammatory Bowel Diseases|December 1, 1999
A genome-wide search identifies potential new susceptibility loci for Crohn's diseaseY Ma, J D Ohmen, Z Li, et al.
Gastroenterology|June 1, 1996
Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroupE A Vasiliauskas, S E Plevy, C J Landers, et al.
Gastroenterology|March 1, 1993
Distinct associations of HLA class II genes with inflammatory bowel diseaseH Toyoda, S J Wang, H Y Yang, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2001
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's diseaseF Cornillie, D Shealy, G D'Haens, et al.
Mucosal Immunology|May 23, 2014
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosisD Q Shih, L Zheng, X Zhang, et al.
The New England Journal of Medicine|October 9, 1997
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study GroupS R Targan, S B Hanauer, S J van Deventer, et al.
Annals of Internal Medicine|September 1, 1991
Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter studyC A Sninsky, D H Cort, F Shanahan, et al.
Gut|October 4, 2008
Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activationH Takedatsu, K D Taylor, L Mei, et al.
Gastroenterology|August 7, 2001
CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's diseaseK A Papadakis, J Prehn, S T Moreno, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Alimentary Pharmacology & Therapeutics|July 13, 2012
Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolismD Q Shih, M Nguyen, L Zheng, et al.
Inflammatory Bowel Diseases|December 1, 1999
A genome-wide search identifies potential new susceptibility loci for Crohn's diseaseY Ma, J D Ohmen, Z Li, et al.
Gastroenterology|June 1, 1996
Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroupE A Vasiliauskas, S E Plevy, C J Landers, et al.
Gastroenterology|March 1, 1993
Distinct associations of HLA class II genes with inflammatory bowel diseaseH Toyoda, S J Wang, H Y Yang, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2001
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's diseaseF Cornillie, D Shealy, G D'Haens, et al.
Mucosal Immunology|May 23, 2014
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosisD Q Shih, L Zheng, X Zhang, et al.
The New England Journal of Medicine|October 9, 1997
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study GroupS R Targan, S B Hanauer, S J van Deventer, et al.
Annals of Internal Medicine|September 1, 1991
Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter studyC A Sninsky, D H Cort, F Shanahan, et al.
Gut|October 4, 2008
Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activationH Takedatsu, K D Taylor, L Mei, et al.
Gastroenterology|August 7, 2001
CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's diseaseK A Papadakis, J Prehn, S T Moreno, et al.
Pageof 12